Literature DB >> 34116063

Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.

Tiffany T Wu1, Sherif A Eldirany2, Christopher G Bunick2, Joyce M C Teng3.   

Abstract

Pachyonychia congenita (PC) is a genetic disorder of keratin that presents with nail dystrophy, painful palmoplantar keratoderma, and other clinical manifestations. We investigated the genotype‒structurotype‒phenotype correlations seen with mutations in keratin genes (keratin [K]6A, K6B, K6C, K16, K17) and utilized protein structure modeling of high-frequency mutations to examine the functional importance of keratin structural domains in PC pathogenesis. Participants of the International PC Research Registry underwent genetic testing and completed a standardized survey on their symptoms. Our results support previous reports associating oral leukokeratosis with K6A mutations and cutaneous cysts, follicular hyperkeratosis, and natal teeth with K17 mutations. Painful keratoderma was prominent with K6A and K16 mutations. Nail involvement was most common in patients with K6A mutation and least common in those with K6C mutation. Across keratin subtypes, patients with coil 2B mutations had the greatest impairment in ambulation, and patients with coil 1A mutations reported more emotional issues. Molecular modeling demonstrated that hotspot missense mutations in PC largely disrupted hydrophobic interactions or surface charge. The former may destabilize keratin dimers/tetramers, whereas the latter likely interferes with higher-order keratin filament formation. Understanding the pathologic alterations in keratin structure improves our knowledge of how PC genotype correlates with clinical phenotype, advancing insight into disease pathogenesis and therapeutic development.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34116063      PMCID: PMC8922998          DOI: 10.1016/j.jid.2021.03.035

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  32 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

2.  Delayed-onset pachyonychia congenita associated with a novel mutation in the central 2B domain of keratin 16.

Authors:  J B Connors; A K Rahil; F J Smith; W H McLean; L M Milstone
Journal:  Br J Dermatol       Date:  2001-05       Impact factor: 9.302

3.  Nail that mutation-keratin 17 defect in late-onset pachyonychia.

Authors:  Frances J D Smith
Journal:  J Invest Dermatol       Date:  2004-04       Impact factor: 8.551

4.  Hendecad repeat in segment 2A and linker L2 of intermediate filament chains implies the possibility of a right-handed coiled-coil structure.

Authors:  David A D Parry
Journal:  J Struct Biol       Date:  2006-04-27       Impact factor: 2.867

Review 5.  Keratin gene mutations in disorders of human skin and its appendages.

Authors:  Jean Christopher Chamcheu; Imtiaz A Siddiqui; Deeba N Syed; Vaqar M Adhami; Mirjana Liovic; Hasan Mukhtar
Journal:  Arch Biochem Biophys       Date:  2010-12-19       Impact factor: 4.013

6.  Pachyonychia congenita patients with mutations in KRT6A have more extensive disease compared with patients who have mutations in KRT16.

Authors:  K M Spaunhurst; A M Hogendorf; F J D Smith; B Lingala; M E Schwartz; A Cywinska-Bernas; K J Zeman; J Y Tang
Journal:  Br J Dermatol       Date:  2012-04       Impact factor: 9.302

7.  Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients.

Authors:  Robyn P Hickerson; Devin Leake; Lana N Pho; Sancy A Leachman; Roger L Kaspar
Journal:  J Dermatol Sci       Date:  2009-08-21       Impact factor: 4.563

8.  Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases.

Authors:  Jéssica González-Ramos; Elena Sendagorta-Cudós; Guillermo González-López; Ander Mayor-Ibarguren; Rosa Feltes-Ochoa; Pedro Herranz-Pinto
Journal:  Dermatol Ther       Date:  2015-10-07       Impact factor: 2.851

9.  Genotype-phenotype correlations among pachyonychia congenita patients with K16 mutations.

Authors:  Teresa Fu; Sancy A Leachman; Neil J Wilson; Frances J D Smith; Mary E Schwartz; Jean Y Tang
Journal:  J Invest Dermatol       Date:  2010-12-16       Impact factor: 8.551

10.  SWISS-MODEL: homology modelling of protein structures and complexes.

Authors:  Andrew Waterhouse; Martino Bertoni; Stefan Bienert; Gabriel Studer; Gerardo Tauriello; Rafal Gumienny; Florian T Heer; Tjaart A P de Beer; Christine Rempfer; Lorenza Bordoli; Rosalba Lepore; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

View more
  1 in total

1.  Treatment of Painful Palmoplantar Keratoderma Related to Pachyonychia Congenita Using EGFR Inhibitors.

Authors:  Céline Greco; Anne-Charlotte Ponsen; Stéphanie Leclerc-Mercier; Joël Schlatter; Salvatore Cisternino; Claude Boucheix; Christine Bodemer
Journal:  Biomedicines       Date:  2022-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.